Thank you for sharing!

Your article was successfully shared with the contacts you provided.
An experimental medication developed by Eli Lilly to slow the progress of dementia failed to show any benefit during a large-scale trial. (Photo: iStock)

As life expectancies increase and a greater portion of our society lives in old age, the search for solutions to dementia are taking on a new urgency as families and the health care system cope with the emotional and financial toll of millions of cognitively-impaired Americans. 

Jack Craver


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.